Compounds > 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline
Page last updated: 2024-08-26

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Atherosclerotic Parkinsonism

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with Atherosclerotic Parkinsonism in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirobe, M; Kotake, Y; Makino, Y; Ohta, S; Tasaki, Y1
Hirobe, M; Kotake, Y; Ogawa, M; Ohta, S; Tasaki, Y; Yoshida, M1
Hirobe, M; Kotake, Y; Ohta, S; Tasaki, Y1
Deleu, D1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T1

Other Studies

5 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Atherosclerotic Parkinsonism

ArticleYear
1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
    Journal of neurochemistry, 1995, Volume: 65, Issue:6

    Topics: Animals; Behavior, Animal; Biogenic Amines; Brain; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Parkinson Disease, Secondary; Tetrahydroisoquinolines

1995
Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.
    Neuroscience letters, 1996, Oct-11, Volume: 217, Issue:1

    Topics: Animals; Brain Chemistry; Injections, Subcutaneous; Isoquinolines; Macaca fascicularis; Male; Neurotoxins; Parkinson Disease, Secondary; Tetrahydroisoquinolines; Time Factors

1996
Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.
    Brain research, 1998, Mar-23, Volume: 787, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Brain Chemistry; Chromatography, Gas; Depression, Chemical; In Vitro Techniques; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Phenethylamines; Selegiline; Tetrahydroisoquinolines

1998
Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Acta neurologica Belgica, 1998, Volume: 98, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Dopamine; Humans; Isoquinolines; Methyltransferases; MPTP Poisoning; Nerve Tissue Proteins; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Salsoline Alkaloids; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

1998
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Brain research, 2001, Jul-13, Volume: 907, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

2001